Qingli Cui

A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer

Qingli Cui, Yanhui Hu, Dongyang Ma et al. · Drug Design Development and Therapy · 2021 · 29 citations · Full text

In situ decorated Au NPs on chitosan-encapsulated Fe3O4-NH2 NPs as magnetic nanocomposite: Investigation of its anti-colon carcinoma, anti-gastric cancer and anti-pancreatic cancer

Xinjie Wang, Hesham S. Almoallim, Qingli Cui et al. · International Journal of Biological Macromolecules · 2020 · 28 citations

Materials Science, Nanomedicine, Nanoparticles +10

Osimertinib Rechallenge With Bevacizumab vs. Chemotherapy Plus Bevacizumab in EGFR-Mutant NSCLC Patients With Osimertinib Resistance

Qingli Cui, Yanhui Hu, Cui Qing-an et al. · Frontiers in Pharmacology · 2022 · 18 citations · Full text

Aqueous extract of Taxus Chinensis (Pilger) Rehd inhibits lung carcinoma A549 cells through the epidermal growth factor receptor/mitogen-activated protein kinase pathway in vitro and in vivo

Qijin Shu, Minhe Shen, Binbin Wang et al. · Journal of Traditional Chinese Medicine · 2014 · 16 citations · Full text

Apatinib combined with PD-1 antibody for third-line or later treatment of advanced gastric cancer

Qingli Cui, Yuefeng Mao, Daoyuan Wu et al. · Frontiers in Oncology · 2022 · 12 citations · Full text